CRGP Treatment

Service Description

CGRP monoclonal antibody treatment works by blocking the action of CGRP, a key chemical involved in migraine. Administered as a once-monthly self-injection using an easy-to-use autoinjector pen, it can be given into the abdomen, upper arm, or thigh. Many people notice improvement within the first three months, with maximum benefit often achieved after up to 12 months of treatment. There should be some effect within three months and a year to reach its full potential.